Provided by Tiger Fintech (Singapore) Pte. Ltd.

Myriad Genetics

6.71
-0.1895-2.75%
Volume:411.42K
Turnover:2.82M
Market Cap:624.38M
PE:-1.55
High:7.02
Open:6.90
Low:6.69
Close:6.90
52wk High:29.30
52wk Low:3.76
Shares:93.04M
Float Shares:85.72M
Volume Ratio:0.75
T/O Rate:0.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3264
EPS(LYR):-1.4051
ROE:-70.03%
ROA:-5.44%
PB:1.61
PE(LYR):-4.78

Loading ...

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

GlobeNewswire
·
Aug 28

Opendoor, SmartRent, Myriad Genetics, Reddit, and Unity Stocks Trade Down, What You Need To Know

stock_story_highlight
·
Aug 21

Myriad Genetics Enters Partnership Agreement to Advance Cancer Diagnostic Technology

Deep News
·
Aug 20

Analysts Are Bullish on These Healthcare Stocks: Myriad Genetics (MYGN), PTC Therapeutics (PTCT)

TIPRANKS
·
Aug 20

Myriad Genetics Teams Up With Angle on Cancer Diagnostics

MT Newswires Live
·
Aug 20

Myriad Genetics Inc. Files Initial Statement of Beneficial Ownership for CFO Benjamin Richard Wheeler

Reuters
·
Aug 20

UBS Sticks to Its Hold Rating for Myriad Genetics (MYGN)

TIPRANKS
·
Aug 19

Myriad Genetics reaffirms FY25 guidance

TIPRANKS
·
Aug 19

Myriad Genetics appoints Ben Wheeler as Chief Financial Officer

TIPRANKS
·
Aug 18

Myriad Genetics Appoints Ben Wheeler as New CFO, Succeeding Scott Leffler

Reuters
·
Aug 18

Myriad Genetics Inc - Promotes Ben Wheeler to CFO

THOMSON REUTERS
·
Aug 18

Myriad Genetics Inc - Scott Leffler to Transition to Consulting Role

THOMSON REUTERS
·
Aug 18

Myriad Genetics Inc - Reaffirms 2025 Financial Guidance

THOMSON REUTERS
·
Aug 18

New Myriad Genetics Survey Uncovers Women Fear Screenings—But Feel Reassured by the Results

GlobeNewswire
·
Aug 13

Myriad Genetics (MYGN) Gets a Buy from Piper Sandler

TIPRANKS
·
Aug 11

UBS Adjusts Price Target on Myriad Genetics to $6 From $7, Maintains Neutral Rating

MT Newswires Live
·
Aug 07

Leerink Partners Sticks to Its Hold Rating for Myriad Genetics (MYGN)

TIPRANKS
·
Aug 07

BUZZ-U.S. STOCKS ON THE MOVE-Novavax, copper miners, Apple

Reuters
·
Aug 07

Hold Rating Maintained for Myriad Genetics Amid Mixed Performance and Strategic Challenges

TIPRANKS
·
Aug 06

Myriad Genetics (MYGN) Q2 Revenue Up 6%

Motley Fool
·
Aug 06